Literature DB >> 18412057

The nosologic relationship between generalized anxiety disorder and major depression.

John M Hettema1.   

Abstract

Generalized anxiety disorder (GAD) has undergone a series of revisions in its diagnostic criteria that has moved it, nosologically, away from its original affiliation with panic disorder (PD) and closer to major depressive disorder (MDD). This, together with its high comorbidity and putative shared genetic risk with MDD, has brought into question its place in future psychiatric nosology, prompting the planners of Diagnostic and Statistical Manual-V (DSM-V) and International Classification of Diseases-11 (ICD-11) to set up a workgroup tasked to better understand the relationship between GAD and MDD. This review attempts to summarize the extant data to compare GAD and MDD on a series of research validators to explore this relationship. Although insufficient data currently exist for GAD in several key validator classes, tentative conclusions can be drawn on the diagnostic status of GAD in relation to MDD. Although GAD possesses substantial overlap with MDD in the areas of genetics, childhood environment, demographics, and personality traits, this tends to hold true for other anxiety disorders (ADs) as well, with the strongest evidence for PD. Data from life events, personality disorders, biology, comorbidity, and pharmacology are mixed, showing some areas of similarity between GAD and MDD but some clear differences, again with a moderate degree of nonspecificity. Thus, although the bulk of evidence supports a close underlying relationship between them, the relatively nonspecific nature of these findings provides little more reason to question the nosologic validity of GAD in relation to MDD than that of some other anxiety disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18412057     DOI: 10.1002/da.20491

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  28 in total

1.  Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder.

Authors:  Alessandro Serretti; Alberto Chiesa; Raffaella Calati; Sylvie Linotte; Othman Sentissi; Konstantinos Papageorgiou; Siegfried Kasper; Joseph Zohar; Diana De Ronchi; Julien Mendlewicz; Daniela Amital; Stuart Montgomery; Daniel Souery
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-09       Impact factor: 5.270

2.  The latent structure and comorbidity patterns of generalized anxiety disorder and major depressive disorder: a national study.

Authors:  Carlos Blanco; José M Rubio; Melanie Wall; Roberto Secades-Villa; Katja Beesdo-Baum; Shuai Wang
Journal:  Depress Anxiety       Date:  2013-06-14       Impact factor: 6.505

3.  Difficulty concentrating in generalized anxiety disorder: An evaluation of incremental utility and relationship to worry.

Authors:  Lauren S Hallion; Shari A Steinman; Susan N Kusmierski
Journal:  J Anxiety Disord       Date:  2017-11-04

4.  The burden of generalized anxiety disorder in Canada.

Authors:  Louise Pelletier; Siobhan O'Donnell; Louise McRae; Jean Grenier
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-02       Impact factor: 3.240

5.  Effect of age on the frequency of anxiety disorders in major depression with psychotic features.

Authors:  Alastair J Flint; Catherine Peasley-Miklus; Eros Papademetriou; Barnett S Meyers; Benoit H Mulsant; Anthony J Rothschild; Ellen M Whyte
Journal:  Am J Geriatr Psychiatry       Date:  2010-05       Impact factor: 4.105

6.  Fetal growth and the lifetime risk of generalized anxiety disorder.

Authors:  Helen-Maria Vasiliadis; Stephen L Buka; Laurie T Martin; Stephen E Gilman
Journal:  Depress Anxiety       Date:  2010-08-23       Impact factor: 6.505

7.  Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses.

Authors:  Michael Maes; Kamila Landucci Bonifacio; Nayara Rampazzo Morelli; Heber Odebrecht Vargas; Estefânia Gastaldello Moreira; Drozdstoy St Stoyanov; Décio Sabbatini Barbosa; André F Carvalho; Sandra Odebrecht Vargas Nunes
Journal:  Neurotox Res       Date:  2018-05-07       Impact factor: 3.911

8.  Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder.

Authors:  Sean D Hood; Dana A Hince; Simon J C Davies; Spilios Argyropoulos; Hayley Robinson; John Potokar; David J Nutt
Journal:  Psychopharmacology (Berl)       Date:  2009-11-21       Impact factor: 4.530

9.  Reexamining associations between mania, depression, anxiety and substance use disorders: results from a prospective national cohort.

Authors:  M Olfson; R Mojtabai; K R Merikangas; W M Compton; S Wang; B F Grant; C Blanco
Journal:  Mol Psychiatry       Date:  2016-05-03       Impact factor: 15.992

10.  Psychophysiological correlates of generalized anxiety disorder with or without comorbid depression.

Authors:  Stefan G Hofmann; Stefan M Schulz; Sanna Heering; Frederick Muench; Lynn F Bufka
Journal:  Int J Psychophysiol       Date:  2010-01-21       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.